Peripheral Neuropathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You must be 18 years of age or older.
- You must have been diagnosed with type 1 or type 2 diabetes.
- You must have a foot ulcer that measures between 1.0 cm² and 5.0 cm² in size after any wound cleaning has been done.
- Your foot ulcer must have been present for at least 4 weeks but no longer than 52 weeks before your first screening visit.
- Your ulcer must be on the foot, with at least half of it located below the ankle bone.
- Your ulcer must be of a certain depth (reaching at least through the skin layers into the fat beneath, and possibly into muscle), but must not expose any tendon or bone (confirm with trial site).
- The blood flow to your affected leg and foot must be adequate, confirmed by one of several standard tests done within 3 months before screening (confirm with trial site).
- If you have more than one foot ulcer, they must be at least 2 cm apart from each other.
- You must be willing to use the prescribed pressure-relieving footwear or device for the entire study.
- You must be able to attend weekly study visits as required.
- You must be willing and able to give your informed consent to take part.
Who may not be able to join:
- People who are not expected to live longer than 6 months are not eligible.
- People whose foot ulcer is caused by something other than diabetes are not eligible.
- People whose target ulcer is currently infected, or who have a skin infection (redness and swelling) around the ulcer, are not eligible.
- People who have a bone infection related to the target ulcer are not eligible.
- People who currently need antibiotic tablets or injections for any infection — either in the ulcer or elsewhere in the body — are not eligible.
- People who are taking immune-suppressing medications or chemotherapy drugs are not eligible (this includes steroid medications above a certain dose).
- People who have had steroid cream or ointment applied directly to the ulcer within the past month are not eligible.
- People who have had a partial amputation on the affected foot that makes it difficult to properly relieve pressure from the ulcer are not eligible.
- People whose ulcer has already shrunk by more than 20% in the 2 weeks before the first screening visit are not eligible.
- People whose ulcer shrinks by 20% or more during the 2-week screening period before the study officially begins are not eligible.
- People who are considered malnourished based on a standard nutrition assessment score are not eligible.
- People who have an active or inactive Charcot foot condition (a serious foot deformity related to nerve damage) that makes it hard to properly relieve pressure from the ulcer are not eligible.
- Women who are pregnant or planning to become pregnant within the next 6 months are not eligible.
- People with severe kidney disease who require dialysis are not eligible.
- People who, in the opinion of the study doctor, have a medical or mental health condition that could affect study results are not eligible.
- People who have received hyperbaric oxygen therapy (a specialised oxygen treatment) or certain advanced wound care products within the 30 days before screening are not eligible.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 888-960-1343
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Efficacy of dhAM + SOC vs SOC
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.